← back to search

Yunkai Dai

Guangzhou University of Chinese Medicine · CN
Area of research
Surgery · Epidemiology
Research interest
Research interests include Medicine, Internal medicine, Meta-analysis, Randomized controlled trial, Helicobacter pylori, and Irritable bowel syndrome.
h-index
citations
245
works
22
NIH funding
primary concept
email

Recent publications

CDH1 genetic variants and its aberrant expression are the risk factors for colorectal cancer metastasis
BMC Gastroenterology 2025cited by 3position: middledoi
Role of CDH1 gene variants and E-cadherin localization in gastric mucosal cancerization
Frontiers in Oncology 2025cited by 3position: middledoi
Mapping the Intellectual Landscape: A 20-Year Bibliometric Analysis of Mechanisms in Metabolic Dysfunction-Associated Steatotic Liver Disease
Hepatic Medicine Evidence and Research 2025cited by 0position: lastdoi
Investigating the role of inflammatory bowel disease-associated gene expression in oral cancer using single-cell RNA sequencing
Clinical & Translational Oncology 2025cited by 0position: lastdoi
Functional gene polymorphisms and expression alteration of selected microRNAs and the risk of various gastric lesions in Helicobacter pylori-related gastric diseases
Frontiers in Genetics 2023cited by 5position: middledoi
Syndrome of liver depression and spleen deficiency is a primary TCM syndrome of response to entecavir + FuZheng HuaYu in patients with HBV-related liver fibrosis
Heliyon 2023cited by 5position: firstdoi
The Single-Nucleotide Polymorphism of miR-27a rs895819 and the Expression of miR-27a in Helicobacter pylori-Related Diseases and the Correlation with the Traditional Chinese Medicine Syndrome
Evidence-based Complementary and Alternative Medicine 2022cited by 4position: middledoi
The efficacy and safety of acupuncture in nonalcoholic fatty liver disease
Medicine 2021cited by 24position: middledoi
Pharmacological treatments of Chinese herbal medicine for irritable bowel syndrome in adults: A network meta-analysis of randomized controlled trials
PLoS ONE 2021cited by 12position: middledoi
Efficacy and safety of Qingre-Chushi therapies in active ulcerative colitis: A network meta-analysis
PLoS ONE 2021cited by 2position: middledoi
Different Traditional Herbal Medicines for the Treatment of Gastroesophageal Reflux Disease in Adults
Frontiers in Pharmacology 2020cited by 16position: firstdoi
Efficacy and safety of non-pharmacological interventions for irritable bowel syndrome in adults
World Journal of Gastroenterology 2020cited by 14position: firstdoi
Interaction of Cyclooxygenase‐2 with <i>Helicobacter pylori</i> Induces Gastric Chronic Nonresolving Inflammation and the Formation of Syndrome of Internal Block of Static Blood in <i>Helicobacter pylori</i>‐Related Gastric Diseases
Evidence-based Complementary and Alternative Medicine 2020cited by 3position: firstdoi
Associations of Interleukin‐1<i>β</i> with <i>H. pylori</i>‐Induced Gastric Atrophy and Syndrome of Dampness‐Heat in the Spleen and Stomach in Subjects with <i>H. pylori</i>‐Related Gastric Diseases
Evidence-based Complementary and Alternative Medicine 2020cited by 2position: middledoi
Efficacy of traditional Chinese medicine for chronic gastritis
Medicine 2019cited by 18position: middledoi
Efficacy of traditional Chinese Medicine for gastric precancerous lesion: A meta-analysis of randomized controlled trials
Complementary Therapies in Clinical Practice 2019cited by 5position: middledoi
Efficacy of Jianpi Liqi therapy for functional dyspepsia
Medicine 2019cited by 4position: middledoi
Efficacy and safety of Modified Tongxie Yaofang in diarrhea-predominant irritable bowel syndrome management: A meta-analysis of randomized, positive medicine-controlled trials
PLoS ONE 2018cited by 25position: firstdoi
The Therapeutic Role of Xenobiotic Nuclear Receptors Against Metabolic Syndrome
Current Drug Metabolism 2018cited by 12position: middledoi
The Role of E-cadherin in Helicobacter pylori-Related Gastric Diseases
Current Drug Metabolism 2018cited by 5position: middledoi
Systematic review and meta-analysis of traditional Chinese medicine in the treatment of constipation-predominant irritable bowel syndrome
PLoS ONE 2017cited by 38position: middledoi
Efficacy and Safety of Modified Banxia Xiexin Decoction (Pinellia Decoction for Draining the Heart) for Gastroesophageal Reflux Disease in Adults: A Systematic Review and Meta‐Analysis
Evidence-based Complementary and Alternative Medicine 2017cited by 22position: firstdoi
Role of Medicinal Plants for Liver‐Qi Regulation Adjuvant Therapy in Post‐stroke Depression: A Systematic Review of Literature
Phytotherapy Research 2016cited by 28position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ling Hu · University of Alabama at Birmingham17 papers (2016–2025)Ru‐Liu Li · Guangzhou University of Chinese Medicine14 papers (2017–2025)Weijing Chen · Guangzhou University of Chinese Medicine13 papers (2017–2025)Yunzhan Zhang · Guangzhou University of Chinese Medicine12 papers (2017–2025)Danyan Li · Guangzhou University of Chinese Medicine10 papers (2017–2025)Yunbo Wu · Guangzhou University of Chinese Medicine7 papers (2020–2025) · 6 papers (2019–2025)Jintong Ye · Guangzhou University of Chinese Medicine6 papers (2017–2023)Meng-xin Huang · Guangzhou University of Chinese Medicine5 papers (2017–2022)Qi Luo · Shandong University5 papers (2020–2025)Huai-geng Pan · Guangzhou University of Chinese Medicine3 papers (2021–2025)Yong Gao · The University of Texas Southwestern Medical Center2 papers (2018–2018)Qi Wang · Hebei Medical University2 papers (2016–2018)Bin Chen · Tufts University2 papers (2020–2020)Chen Xu · University of Shanghai for Science and Technology2 papers (2023–2025)Jianyu Wu · Harbin Medical University2 papers (2020–2025)Peiwu Li · Guangzhou University of Chinese Medicine2 papers (2019–2023)Lin Gong · Guangzhou University of Chinese Medicine2 papers (2020–2020)Chunzhi Tang · Guangzhou University of Chinese Medicine2 papers (2020–2020)Liming Lu · Guangzhou University of Chinese Medicine2 papers (2020–2020)